Learning

February 10, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA ATB increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 11/Februay/2019, 12.19 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA ATB increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 11/Februay/2019, 12.19 am https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-ATB-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-ATB-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg February 10, 2019 February 10, 2019

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA; Paul F. Glenn Center for the Biology of…

February 9, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA ZFAS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 9/Februay/2019, 7.01 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA ZFAS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 9/Februay/2019, 7.01 am https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-ZFAS1inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-ZFAS1inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg February 9, 2019 February 9, 2019

February 6, 2019

Probiotics as learning/memory/cognitive/longevity-enhancer: Probiotic VSL#3 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 27/June/2018, 11.34 pm

Probiotics as learning/memory/cognitive/longevity-enhancer: Probiotic VSL#3 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 27/June/2018, 11.34 pm https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-VSL3-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-VSL3-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg February 6, 2019 February 6, 2019

February 6, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DSCAMAS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 6/Februay/2019, 11.11 pm

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DSCAMAS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 6/Februay/2019, 11.11 pm https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-DSCAMAS1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/02/LncRNA-DSCAMAS1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg February 6, 2019 February 6, 2019

January 25, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA SNHG1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 25/January/2019, 11.55 pm

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA SNHG1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 25/January/2019, 11.55 pm https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-SNGH1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-SNGH1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg January 25, 2019 January 25, 2019

January 24, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA NRF2-AS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 24/January/2019, 8.17 pm

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA NRF2-AS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 24/January/2019, 8.17 pm https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-NR2F2AS1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-NR2F2AS1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene.jpg2_.jpg January 24, 2019 January 24, 2019